SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-22-007196
Filing Date
2022-03-24
Accepted
2022-03-24 17:21:41
Documents
74
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K blcm-20211231.htm   iXBRL 10-K 1867709
2 EX-10.25 exhibit1025mdaccassetpurch.htm EX-10.25 235058
3 EX-10.26 exhibit1026charityemployme.htm EX-10.26 122237
4 EX-21.1 exhibit211subsidiaries2021.htm EX-21.1 2166
5 EX-23.1 exhibit231consentofey.htm EX-23.1 3977
6 EX-31.1 exhibit311-202110k.htm EX-31.1 9131
7 EX-32.1 exhibit321-202110k.htm EX-32.1 5785
13 image_0.jpg GRAPHIC 156
  Complete submission text file 0001628280-22-007196.txt   8782771

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20211231.xsd EX-101.SCH 54810
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20211231_cal.xml EX-101.CAL 68990
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20211231_def.xml EX-101.DEF 306948
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20211231_lab.xml EX-101.LAB 721010
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20211231_pre.xml EX-101.PRE 487380
68 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20211231_htm.xml XML 1303485
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36783 | Film No.: 22767552
SIC: 2834 Pharmaceutical Preparations